BIOMAT Database Logo BIOMAT Database Logo

Cascade filtration for familial hypercholesterolemia. 1991

M Valbonesi, and L Bigi, and M Ferrari, and G Florio

UI MeSH Term Description Entries
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic

Related Publications

M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Successful treatment of homozygous familial hypercholesterolemia using cascade filtration plasmapheresis.
December 2012, Turkish journal of haematology : official journal of Turkish Society of Haematology,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Reverse Cascade Screening for Familial Hypercholesterolemia.
January 2019, Journal of pediatric nursing,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Cascade genetic screening for familial hypercholesterolemia.
December 2004, Clinical genetics,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Cascade Screening for Familial Hypercholesterolemia (FH).
May 2011, PLoS currents,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Cascade screening program for familial hypercholesterolemia.
May 2018, Endocrinologia, diabetes y nutricion,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Effectiveness of cascade filtration plasmapheresis in two patients affected by familial hypercholesterolemia.
January 1995, Journal of clinical apheresis,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Familial homozygous hypercholesterolemia: effective long-term treatment with cascade double filtration plasmapheresis.
January 2001, Blood purification,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Cascade screening for familial hypercholesterolemia: Practical consequences.
November 2017, Atherosclerosis. Supplements,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
The evaluation of cascade testing for familial hypercholesterolemia.
January 2012, American journal of medical genetics. Part A,
M Valbonesi, and L Bigi, and M Ferrari, and G Florio
Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
February 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Copied contents to your clipboard!